Clinical trail results to be released
The 24th Annual Meeting and Scientific Session of the International Society for Heart and Lung Transplantation (ISHLT) will feature presentations and debate on advances and emerging technologies in the fields of late stage heart and lung failure, thoracic transplantation, cell transplantation, and tissue engineering and related infectious disease. Held April 21-24 at the Hilton San Francisco, the meeting will feature original research, plenary sessions and lectures for more than 2,000 attendees from around the globe.
LATE-BREAKING RESULTS FROM CLINICAL TRIALS
Attending media will be the first to learn the results of high-impact transplantation clinical trials presented during special plenary sessions. These include:
The use of genomic medicine to enhance outcomes in heart transplant recipients Definitive studies of newer distinctive strategies of immunosuppression to decrease rejection rates. Immunosuppression involves the medical suppression of the immune system to prevent organ transplant rejection. The latest information on the impact of novel immunosuppression in tackling coronary artery disease after transplantation using intravascular ultrasound Use of novel drug delivery systems such as inhaled cyclosporine after lung transplantation The final scientific program and hotel information are available at www.ishlt.org/meetings.
Media with press credentials are welcome for no charge at all scientific sessions and symposia. A fully equipped and staffed press room with supplemental materials and opportunities for press briefings will be available on site from April 21-24. Every accommodation will be made to fulfill individual requests for interviews and information. Please contact Kelly Goff to register.
Additional information about the meeting will be provided as it becomes available. If you would like to receive updates and news releases, please register using the form below or e-mail your registration information to firstname.lastname@example.org or email@example.com.
The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit organization with more than 2,200 members from 45-plus countries dedicated to the advancement of the science and treatment of end-stage heart and lung diseases. For more information, visit www.ishlt.org.
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.
As a man thinketh in his heart, so he is.